Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong
· Delayed Price · Currency is HKD 8.16
-0.05 (-0.61%)
At close: Dec 5, 2025
HKG:0512 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 28,575 | 16,809 | 14,394 | 16,225 | 22,930 | 24,421 | Upgrade
|
| Market Cap Growth | 72.15% | 16.78% | -11.29% | -29.24% | -6.11% | 70.53% | Upgrade
|
| Enterprise Value | 30,985 | 18,299 | 16,581 | 18,124 | 22,786 | 25,877 | Upgrade
|
| Last Close Price | 8.16 | 4.59 | 3.71 | 4.04 | 5.53 | 5.81 | Upgrade
|
| PE Ratio | 13.73 | 6.81 | 7.66 | 7.80 | 9.54 | 13.62 | Upgrade
|
| Forward PE | 13.32 | 8.11 | 7.31 | 7.90 | 9.61 | 15.87 | Upgrade
|
| PS Ratio | 2.44 | 1.44 | 1.37 | 1.70 | 2.67 | 3.84 | Upgrade
|
| PB Ratio | 1.65 | 1.02 | 0.94 | 1.14 | 1.71 | 2.15 | Upgrade
|
| P/TBV Ratio | 2.26 | 1.28 | 1.12 | 1.34 | 1.95 | 2.48 | Upgrade
|
| P/FCF Ratio | 24.10 | 12.52 | 7.43 | 13.34 | 14.95 | 19.59 | Upgrade
|
| P/OCF Ratio | 16.35 | 8.86 | 5.94 | 8.81 | 11.43 | 16.77 | Upgrade
|
| EV/Sales Ratio | 2.65 | 1.57 | 1.58 | 1.90 | 2.65 | 4.07 | Upgrade
|
| EV/EBITDA Ratio | 11.52 | 6.84 | 5.16 | 5.83 | 9.14 | 12.59 | Upgrade
|
| EV/EBIT Ratio | 14.42 | 8.24 | 5.80 | 6.60 | 10.50 | 14.51 | Upgrade
|
| EV/FCF Ratio | 26.13 | 13.63 | 8.56 | 14.90 | 14.85 | 20.75 | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.22 | 0.32 | 0.27 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 1.84 | 1.63 | 1.05 | 1.42 | 1.46 | 1.18 | Upgrade
|
| Debt / FCF Ratio | 3.89 | 3.31 | 1.76 | 3.68 | 2.38 | 1.96 | Upgrade
|
| Asset Turnover | 0.46 | 0.49 | 0.47 | 0.44 | 0.45 | 0.41 | Upgrade
|
| Inventory Turnover | 3.66 | 3.56 | 2.94 | 2.94 | 3.23 | 2.62 | Upgrade
|
| Quick Ratio | 0.99 | 1.01 | 0.98 | 0.86 | 1.00 | 1.00 | Upgrade
|
| Current Ratio | 1.20 | 1.22 | 1.22 | 1.07 | 1.22 | 1.24 | Upgrade
|
| Return on Equity (ROE) | 12.37% | 15.51% | 12.86% | 15.18% | 19.41% | 17.94% | Upgrade
|
| Return on Assets (ROA) | 4.77% | 5.84% | 7.96% | 7.91% | 7.13% | 7.24% | Upgrade
|
| Return on Capital (ROIC) | 5.79% | 7.00% | 9.57% | 9.60% | 8.78% | 9.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.90% | 12.10% | 17.00% | 17.30% | 14.00% | 14.10% | Upgrade
|
| Earnings Yield | 7.28% | 14.69% | 13.06% | 12.82% | 10.48% | 7.34% | Upgrade
|
| FCF Yield | 4.15% | 7.99% | 13.46% | 7.50% | 6.69% | 5.11% | Upgrade
|
| Dividend Yield | 3.19% | 5.67% | 7.01% | 3.46% | 1.99% | 1.89% | Upgrade
|
| Payout Ratio | 43.19% | 36.88% | 26.43% | 18.78% | 16.25% | 18.09% | Upgrade
|
| Buyback Yield / Dilution | -0.13% | 0.17% | 0.97% | 0.16% | -2.98% | -2.19% | Upgrade
|
| Total Shareholder Return | 3.06% | 5.83% | 7.99% | 3.62% | -1.00% | -0.30% | Upgrade
|
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.